| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OTLC | Common Stock | Purchase | $8,925 | +425,000 | +0.46% | $0.0210 | 92,044,217 | 29 Jun 2023 | Direct | |
| transaction | OTLC | Common Stock | Purchase | $1,950 | +75,000 | +0.08% | $0.0260 | 91,619,217 | 28 Jun 2023 | Direct | |
| holding | OTLC | Common Stock | 16,780,384 | 28 Jun 2023 | By Autotelic, Inc. | ||||||
| holding | OTLC | Common Stock | 6,872,529 | 28 Jun 2023 | By Spouse |
On June 28, 2023, Dr. Trieu purchased 75,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.026. Further, on June 29, 2023, Dr. Trieu purchased 425,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity, from the open market at a price of $0.021.